These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 24845943)
1. On the clinical evidence leading to tetrazepam withdrawal. Proy-Vega B; Aguirre C; de Groot P; Solís-García del Pozo J; Jordán J Expert Opin Drug Saf; 2014 Jun; 13(6):705-12. PubMed ID: 24845943 [TBL] [Abstract][Full Text] [Related]
2. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database. Pageot C; Bezin J; Smith A; Arnaud M; Salvo F; Haramburu F; Bégaud B; Pariente A; Drug Saf; 2017 Nov; 40(11):1099-1107. PubMed ID: 28664354 [TBL] [Abstract][Full Text] [Related]
3. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Olivier P; Montastruc JL Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082 [TBL] [Abstract][Full Text] [Related]
4. Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? Paludetto MN; Olivier-Abbal P; Montastruc JL Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1289-94. PubMed ID: 22961933 [TBL] [Abstract][Full Text] [Related]
5. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010]. N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD Therapie; 2012; 67(3):251-6. PubMed ID: 22874492 [TBL] [Abstract][Full Text] [Related]
6. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions. Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924 [TBL] [Abstract][Full Text] [Related]
7. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database. Durrieu G; Olivier P; Bagheri H; Montastruc JL; Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209 [TBL] [Abstract][Full Text] [Related]
8. The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals. Arnaiz JA; Carné X; Riba N; Codina C; Ribas J; Trilla A Eur J Clin Pharmacol; 2001 Apr; 57(1):89-91. PubMed ID: 11372600 [TBL] [Abstract][Full Text] [Related]
9. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center. Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533 [TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation. Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G; Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523 [TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database. Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL; Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603 [TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. Jong MC; Jong MU; Baars EW Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1295-301. PubMed ID: 22692862 [TBL] [Abstract][Full Text] [Related]
13. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Wahab IA; Pratt NL; Wiese MD; Kalisch LM; Roughead EE Pharmacoepidemiol Drug Saf; 2013 May; 22(5):496-502. PubMed ID: 23412832 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Lapeyre-Mestre M; Grolleau S; Montastruc JL; Fundam Clin Pharmacol; 2013 Apr; 27(2):223-30. PubMed ID: 21929527 [TBL] [Abstract][Full Text] [Related]
15. [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)]. Pochard L; Hauviller L; Cuzin L; Eyvrard F; Sommet A; Montastruc JL; Bagheri H Therapie; 2014; 69(2):149-55. PubMed ID: 24926633 [TBL] [Abstract][Full Text] [Related]
16. Acute generalized exanthematous pustulosis due to tetrazepam. Thomas E; Bellón T; Barranco P; Padial A; Tapia B; Morel E; Alves-Ferreira J; Martín-Esteban M J Investig Allergol Clin Immunol; 2008; 18(2):119-22. PubMed ID: 18447141 [TBL] [Abstract][Full Text] [Related]
17. Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance. Pinheiro L; Blake K; Januskiene J; Yue QY; Arlett P Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):705-12. PubMed ID: 27004571 [TBL] [Abstract][Full Text] [Related]
18. Early identification of adverse drug reactions from search log data. White RW; Wang S; Pant A; Harpaz R; Shukla P; Sun W; DuMouchel W; Horvitz E J Biomed Inform; 2016 Feb; 59():42-8. PubMed ID: 26610385 [TBL] [Abstract][Full Text] [Related]
19. Current state of biologic pharmacovigilance in the European Union: improvements are needed. Felix T; Jordan JB; Akers C; Patel B; Drago D Expert Opin Drug Saf; 2019 Mar; 18(3):231-240. PubMed ID: 30714424 [TBL] [Abstract][Full Text] [Related]